ATLANTA, Sept. 6, 2016 /PRNewswire/ -- Craneware plc
(AIM: CRW.L), the healthcare market leader in automated value cycle
solutions, announced results for its 2016 fiscal year that ended
June 30, 2016.
Financial Highlights (U.S. dollars)
- Total Contract Value in the year continues at record levels of
$82.3m (FY15: $72.9m)
- New sales increased by 63% to $58.6m (FY15: $35.9m)
- Renewal rate remains above 100% by dollar value
- Revenue increased 11% to $49.8m
(FY15: $44.8m)
- Adjusted EBITDA1. increased by 10% to
$15.9m (FY15: $14.4m)
- Profit before tax increased by 10% to $13.9m (FY15: $12.5m)
- Basic adjusted EPS increased 13% to $0.429 (FY15: $0.378) and adjusted diluted EPS has increased to
$0.423 (FY15: $0.375)
- Continued operating cash conversion above 100% of Adjusted
EBITDA
- Cash at year-end of $48.8m (FY15:
$41.8m) after payment of $6m dividend to shareholders
- Proposed final dividend of 9p (12
cents) per share giving a total dividend for the year of
16.5p (22 cents) per share (FY15: 14p
(22 cents) per share)
1. Adjusted EBITDA refers to earnings
before acquisition and share related transaction costs, interest,
tax, depreciation, amortization and share based payments.
Operational Highlights (Finals)
- U.S. healthcare market continues its evolution towards
value-based care with a critical dependency on accurate financial
and operating data
- Further expansion of the product suite to support the value
cycle, including:
- Development of Trisus Patient Payment Module, a patient
engagement and access gateway product, on track to launch during
calendar 2016
- Launch of Craneware Healthcare Intelligence, a new business
unit, developing solutions to address an emerging but significant
market opportunity for healthcare cost analytics
- Signed two significant five year contracts, worth a combined
$15.5m
- Continued high levels of customer retention
- Total visible revenue increased 23% to $149.1m (FY15 same 3 year period: $121.1m)
"As the market continues to evolve, Craneware is in a stronger
position than ever," said Keith
Neilson, CEO of Craneware. "U.S. healthcare providers are
seeking the solutions to address the challenges the new value-based
reimbursement environment brings to them, and we believe that by
expanding the products in our value cycle suite, we are able to
address these challenges. We are confident that the ongoing
investment we are making, combined with our continuing sales
successes, mean we are well positioned to deliver continued future
growth as well as increasing stakeholder value."
About Craneware
Craneware (AIM: CRW.L) is the leader in automated value cycle
solutions that help provider organizations discover, convert
and optimize assets to achieve the best clinical outcomes
and financial performance. Our solutions
normalize disparate data sets, bringing in up-to-date
regulatory and financial compliance data to deliver value at
the points where clinical and operational data transform into
financial transactions, creating actionable insights that enable
informed tactical and strategic decisions. Learn more
at Craneware.com.
Logo - http://photos.prnewswire.com/prnh/20121221/CL33999LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/craneware-announces-year-end-financial-results-for-fiscal-year-2016-300323022.html
SOURCE Craneware